Belantamab-mafodotin is an innovative and selective treatment for multi-refractory/relapsed
multiple myeloma (MM) patients; however, available real-life experiences on efficacy and …

Pituitary adenylate cyclase-activating polypeptide (PACAP) is a multifunctional neuropeptide
with well-known anti-inflammatory, antioxidant, antitumor, and immunomodulatory effects …

Background Daratumumab, an anti-CD38 monoclonal antibody, is used for treatment of
multiple myeloma (MM) and light chain amyloidosis at an intravenous dosage of 16 mg/kg or …

Background Viral reactivations are frequent in hematologial patients due to their cancer‐
related and drug‐induced immunosuppressive status. Daratumumab, an anti‐CD38 …

Studies over the past years have provided evidence that Toll-like receptor (TLRs) activation
in multiple myeloma (MM) cells induces heterogeneous functional responses including cell …

Daratumumab, an anti-CD38 monoclonal antibody, is worldwide approved for treatment of
newly diagnosed and relapsed/refractory multiple myeloma (MM) patients and is available …

Acute kidney injury (AKI) is a common complication post-cardiac surgery, impacting short-
and long-term survival. Free light chains (FLCs) are being explored as markers for …

Multiple myeloma is the most frequent malignant monoclonal gammopathy characterized by
plasma cell proliferation and monoclonal M-protein production as consequence. Gold …

Sažetak Uvod: Multipli mijelom je maligna hematološka bolest koja se javlja kao posljedica
nekontrolirane klonalne proliferacije plazma stanica. Najčešće se javlja kod starijih …